Moolec Science SA (NASDAQ:MLEC – Get Free Report) was the target of a large decrease in short interest in August. As of August 14th, there was short interest totaling 2,933 shares, a decrease of 35.0% from the July 30th total of 4,512 shares. Currently, 0.5% of the company’s stock are short sold. Based on an average trading volume of 2,784 shares, the days-to-cover ratio is presently 1.1 days.
Institutional Trading of Moolec Science
An institutional investor recently bought a new stake in Moolec Science stock. Citadel Advisors LLC purchased a new position in shares of Moolec Science SA (NASDAQ:MLEC – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned about 0.90% of Moolec Science as of its most recent SEC filing. 0.07% of the stock is currently owned by hedge funds and other institutional investors.
Moolec Science Trading Down 0.7%
Shares of Moolec Science stock opened at $6.84 on Thursday. The company has a fifty day simple moving average of $7.23 and a 200-day simple moving average of $8.28. Moolec Science has a 12-month low of $3.08 and a 12-month high of $23.22. The company has a current ratio of 0.15, a quick ratio of 0.08 and a debt-to-equity ratio of 0.79. The stock has a market cap of $4.97 million, a price-to-earnings ratio of -0.21 and a beta of 0.26.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on MLEC
About Moolec Science
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Featured Stories
- Five stocks we like better than Moolec Science
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.
